Pathoetiology of multiple sclerosis: Are we barking up the wrong tree?

39Citations
Citations of this article
99Readers
Mendeley users who have this article in their library.

Abstract

Despite a century of intensive investigation, the underlying cause of multiple sclerosis has eluded us. It is clear that there exists a prominent progressive degenerative phenotype together with an important autoimmune inflammatory component, and careful histopathological examination always shows, to a greater or lesser degree, concomitant degeneration/demyelination and adaptive T cell-dependent immune responses. Given this picture, it is difficult, if not impossible, to definitively say whether degeneration or autoimmunity is the initiator of the disease. In this review, I put forward the evidence for and against both models and speculate that, in contrast to the accepted view, it is equally likely that multiple sclerosis may be a degenerative disease that secondarily elicits an autoimmune response, and suggest how this might influence therapeutic approaches. © 2013 Faculty of 1000 Ltd.

Cite

CITATION STYLE

APA

Stys, P. K. (2013). Pathoetiology of multiple sclerosis: Are we barking up the wrong tree? F1000Prime Reports, 5. https://doi.org/10.12703/P5-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free